Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.42 USD | -1.38% | -5.31% | -28.53% |
Financials (USD)
Sales 2024 * | 26.32M | Sales 2025 * | 163M | Capitalization | 1.94B |
---|---|---|---|---|---|
Net income 2024 * | -260M | Net income 2025 * | -219M | EV / Sales 2024 * | 66.5 x |
Net cash position 2024 * | 193M | Net cash position 2025 * | 111M | EV / Sales 2025 * | 11.2 x |
P/E ratio 2024 * |
-7.91
x | P/E ratio 2025 * |
-10.1
x | Employees | 268 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.58% |
Latest transcript on Rocket Pharmaceuticals, Inc.
1 day | -1.38% | ||
1 week | -5.31% | ||
Current month | -0.46% | ||
1 month | -9.35% | ||
3 months | -26.84% | ||
6 months | -3.73% | ||
Current year | -28.53% |
Managers | Title | Age | Since |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 18-01-03 |
Kinnari Patel
PSD | President | 46 | 18-01-03 |
Chief Tech/Sci/R&D Officer | 60 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pedro Granadillo
BRD | Director/Board Member | 77 | 18-01-03 |
Carsten Boess
BRD | Director/Board Member | 57 | 15-12-31 |
David Southwell
BRD | Director/Board Member | 63 | 14-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.15% | 2 M€ | -.--% | ||
0.13% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | 0.00% | - | |
0.06% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 21.42 | -1.38% | 584,106 |
24-05-23 | 21.72 | -3.21% | 765,540 |
24-05-22 | 22.44 | +0.49% | 676,240 |
24-05-21 | 22.33 | -2.19% | 527,713 |
24-05-20 | 22.83 | +0.93% | 471,940 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.53% | 1.97B | |
+12.30% | 116B | |
+12.15% | 106B | |
-8.14% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-15.33% | 16.33B | |
+5.80% | 14.14B | |
+28.03% | 12.02B |
- Stock Market
- Equities
- RCKT Stock